47.19.Z - Other retail sale in non-specialised stores
10.89.Z - Manufacture of other food products not elsewhere classified
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.46.Z - Wholesale of pharmaceutical goods
47.11.Z - Retail sale in non-specialised stores with food, beverages or tobacco predominating
47.91.Z - Retail sale via mail order houses or via Internet
72.19.Z - Other research and experimental development on natural sciences and engineering
86.22.Z - Specialist medical practice activities
86.90.D - Paramedical activities
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | 4,4 | -97,5 | -7,2 | 92,6 |
Gross profit (loss) | 1 | -98,4 | -15,2 | 84,6 |
EBITDA | 4,4 | -98,1 | -6,7 | 93,2 |
Short time liabilities | 147,4 | 174,4 | 164,9 | -5,4 |
Other operating costs | 0 | 0,6 | 0,3 | -51,6 |
Equity capital | -18,6 | -117 | -132,3 | -13 |
Operating profit (EBIT) | 4,4 | -98,1 | -7,5 | 92,3 |
Assets | 128,7 | 57,3 | 32,7 | -43 |
Net profit (loss) | 1 | -98,4 | -15,2 | 84,6 |
Cash | 0,8 | 8,3 | 13,3 | 59,5 |
Liabilities and provisions for liabilities | 147,4 | 174,4 | 164,9 | -5,4 |
Net income from sale | 271,8 | 271,7 | 234,9 | -13,5 |
Working assets | 128,7 | 57,3 | 32,7 | -43 |
Other income costs | 0 | 0 | 0 | -100 |
Depreciation | 0 | 0 | 0,8 | -∞ |
% | % | % | p.p. | |
Profitability of capital | -5,6 | 84,1 | 11,5 | -72,6 |
Equity capital to total assets | -14,5 | -204,2 | -404,5 | -200,3 |
Gross profit margin | 0,4 | -36,2 | -6,5 | 29,7 |
EBITDA Margin | 1,6 | -36,1 | -2,8 | 33,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 198 | 234 | 256 | 22 |
Current financial liquidity indicator | 0.8736280798912048 | 0.3286895155906677 | 0.19820436835289001 | -0,1 |
Net dept to EBITDA | 12.604697227478027 | -1.1555911302566528 | -14.325900077819824 | -13,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane